Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A. (Q33382481)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A. |
scientific article |
Statements
1 reference
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A. (English)
1 reference
Vera J Suman
1 reference
Lisa A Kottschade
1 reference
Domingo G Perez
1 reference
Tom R Fitch
1 reference
Thomas Amatruda
1 reference
Roscoe F Morton
1 reference
Shamim Z Jilani
1 reference
Costas L Constantinou
1 reference
James R Egner
1 reference
Svetomir N Markovic
1 reference
1 January 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference